Media kit on COVID-19

Last update: May, 4, 2021

“66,000 Siemens Healthineers colleagues are sparing no effort and working wherever and however they can to provide clinical experts with the help and technical solutions they need in their fight against COVID-19.”

Bernd Montag, CEO Siemens Healthineers

Published on March 24, 2020

News

Link to all press releases

: The CLINITEST Rapid COVID-19 Antigen Self-Test can be used by laypersons 12 and older, with or without symptoms, to detect the SARS-CoV-2 virus.
Rapid antigen testing provides individuals with results in just 15 minutes in any setting, including the comfort of their homes. This information can help reduce the risk of exposure for families, schools, and communities.
Siemens Healthineers is among the first to supply a COVID-19 test for home use.
Link to the press release
: The CLINITEST Rapid COVID-19 Antigen Self-Test¹, distributed by Siemens Healthineers, has received special approval from the BfArM for use by lay persons
The self-test will be introduced to the market shortly through selected channels
According to the manufacturer, the test can help contain the spread of the SARS-CoV-2 virus with a sensitivity of 97.25 percent and a specificity of 100 percent
Link to the press release
: The Siemens Healthineers SARS-CoV-2 Antigen Assay (CoV2Ag) offers an accurate, high-capacity testing solution to diagnose COVID-19.
CoV2Ag offers testing for current infection worldwide on a widely available installed base of automated immunoassay analyzers.
The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples.
Link to the press release
: The CLINITEST Rapid COVID-19 Antigen Test, distributed by Siemens Healthineers, can now be used with swabs from the frontal (anterior) part of the nose, in addition to the nasopharyngeal swab method.
The new anterior method offers 97.3% sensitivity and 100% specificity.
This new sampling method can be used with existing test kits in the field, allowing for simplified application and thus broader utility in professional settings.
Link to the press release
: The Siemens Healthineers SARS-CoV-2 IgG Antibody Test, available under CE Mark, has proven to measure neutralizing antibodies. The company has submitted to the FDA under EUA.
As SARS-CoV-2 vaccines become available, Siemens Healthineers is ready with fully automated antibody tests that can be used to help inform whether broad vaccination programs are working.
Reliable antibody tests are a valuable tool to measure the effectiveness of vaccines.
Link to the press release
: The CLINITEST Rapid COVID-19 Antigen Test helps identify infected individuals in 15 minutes so they can isolate sooner and avoid spreading COVID-19
Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, offers flexibility to test in locations that benefit from immediate results
Test to be launched in CE mark countries; plans to submit to FDA for Emergency Use Authorization
Link to the press release
: The collaboration will standardize SARS-CoV-2 assays by defining concentrations of antibodies to specific viral proteins to confer neutralization that could one day be extrapolated to thresholds considered sufficient to confer immunity.
Standardization across manufacturers is also expected to improve patient care by enabling long-term antibody level comparison.
Link to the press release
: The SARS-CoV-2 IgG Antibody Test offers the first EUA-authorized semi-quantitative assay to help clinicians assess the level of an individual‘s immune response.
With this numerical result expressed as index value, clinicians will be better equipped to evaluate the duration and level of an individual’s immune response.
The SARS-CoV-2 IgG antibody test offers 100% sensitivity¹ and 99.9% specificity, which is critical for detecting adaptive immune response accurately.
The test also attained the CE-mark and is now broadly available globally.
: Siemens Healthineers started shipping its total antibody tests globally, including to the largest analyzer installed base in the U.S.
The company has a total of 20,000 systems worldwide and will ramp up its production capacity to more than 50 million antibody tests per month as the pandemic evolves.
The total antibody test has demonstrated 100 percent sensitivity and 99.8 percent specificity in identifying SARS-CoV-2 antibodies in as few as 10 minutes.
The SARS-CoV-2 total antibody test is CE marked and the company is pursuing FDA Emergency Use Authorization (EUA).
FDA authorized EUA for the company’s real-time PCR molecular SARS-CoV-2 detection test kit, which demonstrates 100 percent positive percent agreement and 100 percent negative percent agreement. The company plans to ship more than 2.5 million molecular PCR tests per month worldwide as production capacity increases.
Link to the press release
: State Ministry of Health and Care to purchase wide range of equipment for diagnosis and monitoring of Covid-19 patients
Siemens Healthineers supplies 25 computed tomographs (CT) at short notice, including 12 container solutions, 16 mobile X-ray machines, 300 blood gas analyzers and a large quantity of molecular diagnostic tests to detect SARS-CoV-2 virus to clinics throughout Bavaria
Mobile CT solutions for flexible expansion of diagnostic capacities for Covid-19 patients are already in use in numerous countries worldwide
Linkt to the press release

Image Gallery

High quality and targeting the right protein are all essential to ensure we effectively manage the threat of COVID-19. See here all information on the total antibody test at a glance. — Total Antibody Test At a Glance
High quality and targeting the right protein are all essential to ensure we effectively manage the threat of COVID-19. See here all information on the total antibody test at a glance.
Download Image

What the lungs of COVID-19 patients look like — What the lungs of COVID-19 patients look like
The images taken with the Somatom go.Up computer tomograph from Siemens Healthineers show the lung changes associated with confirmed COVID-19 disease. The densifications correspond to inflammatory processes in the lung tissue. The images (left and middle) use a special visualization technique that is also used in the film industry – Cinematic Rendering. For comparison the conventional CT sectional image on the right.
Syngo.via Cinematic Rendering image courtesy of CHR Verviers East Belgium.
Download Image

What the lungs of COVID-19 patients look like — What the lungs of COVID-19 patients look like
The images taken with the Somatom go.Up computer tomograph from Siemens Healthineers show lung changes associated with confirmed COVID-19 disease. The densifications correspond to inflammatory processes in the lung tissue. The images (left and top right) use a special visualization technique that is also used in the film industry – Cinematic Rendering. For comparison the conventional CT sectional image on the lower right.
Syngo.via Cinematic Rendering image courtesy of CHR Verviers East Belgium.
Download image

Siemens Healthineers responded immediately after the SARS-CoV-2 outbreak in Wuhan and donated medical systems to fight the virus within a very short time. — Siemens Healthineers responded immediately after the SARS-CoV-2 outbreak in Wuhan and donated medical systems to fight the virus within a very short time. In addition to the Somatom go.Top CT scanner, Siemens Healthineers provided local hospitals with several ultrasound machines and digital mobile X-ray systems. Those equipment plays a crucial role in the diagnosis and monitoring of COVID-19, the lung disease caused by the virus.
Download images

Test detects antibodies to spike protein – a key protein: Importantly, the test detects antibodies to a key protein on the surface of the SARS-CoV-2 virus—a spike protein, which binds the virus to cells with a distinct human receptor found in lungs, heart, multiple organs and blood vessels. Studies indicate that certain (neutralizing) antibodies to the spike protein can disarm SARS-CoV-2. Multiple potential vaccines in development for SARS-CoV-2 include the spike protein within their focus.

Siemens Healthineers ramps up production capacity: Siemens Healthineers plans to ship more than 50 million antibody tests per month worldwide as production capacity increases. Find here footage from our sites in Tarrytown (NY) and Walpole (MA) to use for your broadcast. If you are interested in the high-res files of the footage, please contact the press team: press.team@siemens-healthineers.com.This test has not been FDA cleared or approved.

Siemens Healthineers ramps up production capacity: Siemens Healthineers plans to ship more than 2.5 million molecular PCR tests per month worldwide as production capacity increases. Find here footage from our site in Marburg, Germany, to use for your broadcast. If you are interested in the high-res files of the footage, please contact the press team: press.team@siemens-healthineers.com.

Download image

Footage of laboratory diagnostics: Siemens Healthineers makes a contribution to fight the current COVID-19 global pandemic significantly through expanding its infectious disease testing capabilities. If you are interested in the high-res files of the footage, please contact the press team: press.team@siemens-healthineers.com.

Download image

Blood gas systems: Blood gas systems support the monitoring of ventilated patients. This footage shows how the systems are used in critical care. To be seen: epoc Blood Analysis System (00:01-00:03), RAPIDPoint 500e Blood Gas System (00:22-00:32). The footage shows the blood analyzer epoc and RAPIDpoint 500e (start image: epoc). If you are interested in the high-res files of the footage, please contact the press team: press.team@siemens-healthineers.com.

Background

Three questions to Sebastian Kronmueller, Head of Molecular Diagnostics | May 26, 2020

Link to the interview

The molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay test kit

Frequently asked questions on medical devices in use

Learn how our systems as well as our tests are used in the diagnosis and course of the disease of COVID-19 patients.

Link to frequently asked questions

Interview with Wolfgang Heimsch, President Customer Service: Investments in recent years are paying off | April 16, 2020

Link to the interview

cs-virtual_technical_training

Managing coagulation abnormalities in COVID-19 patients

Hemostasis and COVID-19

COVID-19: Resources & Updates

By gathering externally published information from trusted sources, our editorial team aims to provide useful information for healthcare providers fighting the virus worldwide.

Link to Resources & Updates

For any questions, please reach out to press office in our contact page.

Press contact